Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight
NeutralFinancial Markets

Novo Nordisk's CEO is navigating a challenging period marked by a significant board shakeup and increasing competition from Pfizer. This situation is crucial as it could impact the company's strategic direction and market position, highlighting the importance of strong leadership in times of change.
— Curated by the World Pulse Now AI Editorial System











